Accreditation Council for Medical Affairs (ACMA)
ACMA leads a transformative healthcare movement, partnering with 250+ pharmaceutical companies to pioneer higher standards in the life sciences.
4.8 /5 - BCMAS Ratings on Google
ACMA is accredited by IACET/ANSI
Who we are
At ACMA, we're at the forefront of a transformative movement in healthcare. With over 250 pharmaceutical companies as our allies, we're redefining what it means to serve in the life sciences sector. We're not just participants; we're pioneers, committed to elevating the standards of medical affairs, market access, reimbursement and healthcare practices globally.
Our mission
To establish a higher level of global standards of excellence in partnership with pharmaceutical, biotech, medical device, diagnostic and healthcare fields through accredited training and technical solutions that improve patient outcomes and instill a higher level of integrity and excellence across the life sciences industry.
We believe that the foundation of exceptional patient care is built on the expertise and ethical conduct of those who serve in the life sciences.
Through our efforts, we're creating a culture of continuous improvement, where best practices in patient outcomes and healthcare provider interactions are not just goals, but guarantees.
What sets us apart?
What makes ACMA unique is our unwavering dedication to the betterment of healthcare through technology, education, accreditation, and advocacy.
We champion the cause of elevating competencies within the pharmaceutical and healthcare sectors, ensuring that every professional's skills are not only up-to-date but also aligned with the highest ethical standards. Our commitment extends beyond the individual; it's about uplifting the entire ecosystem to ensure that patient care is always at the forefront.
Our vision for the future
We envision a world where trust in the life sciences industry is unshakeable, where every patient interaction is informed by the highest standards of knowledge and care. In this future, ACMA's role as a catalyst for change is recognized globally, as we continue to advocate for practices that prioritize patient well being above all else. We see a landscape where transparency, ethical practices, and cutting edge innovation converge to drive breakthrough therapies and improved health outcomes. Through collaborative partnerships and advanced technologies, we aim to enhance accessibility to life saving treatments worldwide, reduce healthcare disparities, and foster an environment of continuous learning and improvement across the industry.
Join us
Join the ACMA movement, now in 80+ countries, and be part of a community that values integrity, excellence, and the relentless pursuit of better healthcare for all. Together, we're not just changing standards; we're changing lives, one patient at a time. Let's build a future where excellence in healthcare is the norm, not the exception.
ACMA Featured in the Media
Establishing standards of excellence in the life sciences
Accredited Certification
Thousands of certified ACMA industry professionals from the top 250+ pharma/biotech companies and healthcare systems worldwide
Global
With users in over 80+ countries, the ACMA has developed customized certification & training programs with country & region specific content.
Leadership
The ACMA was invited by the US Congress Health sub-committee as a thought leader to discuss professional standards and has been the recipient of several prestigious awards in the life sciences.
Research Driven
Supported by evidence and research, ACMA educational programs make a significant difference.
Unlock your competitive edge and accelerate sustainable growth in the life sciences
- Educational Solutions
- Digital Solutions
- Advisory Services
A commitment to social responsibility
Scholarships
The ACMA has assisted with $750,000+ in scholarship money to underprivileged professionals around the world.
Advocacy
The ACMA has been invited by the United States Congress Health Subcommittee to discuss the importance of professional standards for medical science liaison and medical affairs professionals.
Diversity and inclusion
We're committed to actions and policies that ensure everyone at the ACMA, as well as our clients and partners, feels welcome and is treated with dignity and respect.
Our History
2015
Advisory Board
The ACMA is founded and convenes an advisory board with healthcare thought leaders across the pharmaceutical, medicine, and academia industries. The board gained insights into the professional development needs of life sciences professionals with a particular focus on Medical Science Liaisons (MSLs) and Medical Affairs professionals.
2016
Accredited Certification
The Board Certified Medical Affairs Specialist (BCMAS) program is launched and quickly becomes recognized as the certification standard of excellence for Medical Science Liaisons (MSLs) and Medical Affairs professionals. The ACMA becomes the first and only accredited organization offering board certification for Medical Affairs and MSLs.
2017
Global Growth
The BCMAS program expands globally, with ACMA developing localized content for international regulatory needs. ACMA also introduces the Pharmaceutical Representative Certification (PRC) program for U.S. localities requiring credentialing, like Illinois and Washington D.C.
2018
Certificate Programs
The ACMA launches several certificate programs such as the Regulatory Affairs Expert Program, Clinical Development Expert Program (CDEP), and more. The ACMA is featured in Forbes, Pharmaceutical Executive and ABC News for its work in raising the bar in the pharmaceutical industry.
2019
Certification Expansion
The ACMA launches the Prior Authorization Certified Specialist (PACS) program and establishes the National Board of Prior Authorization Specialists. The ACMA also launches ACMA Society to help bring members of the life sciences community closer together.
2020
Technology
ACMA introduces technology solutions for life sciences, including ACMA Predict, a sentiment analysis platform for healthcare and pharma. ACMA is recognized as the Exemplar Training Organization of the Year in Life Sciences by IACET/ANSI.
2021
United States Congress
The ACMA is invited by the U.S. Congress' House Committee on Energy and Commerce's Health Subcommittee to discuss Pharmaceutical Industry standards for Medical Science Liaison (MSL) and Medical Affairs professionals.
2022
Leadership
ACMA is considered a leader in the life sciences industry. ACMA leads a healthcare transformation, partnering with 250+ pharmaceutical companies. We elevate global standards in medical affairs, market access, reimbursement, and healthcare practices across the life sciences sector.
2023
ACMA Introduces AI
ACMA introduces An AI enabled, cloud based, sophisticated machine learning tool that is trained on the largest compendium of data in the life sciences. It can be custom trained on your internal data (clinical studies, SOPs, articles, etc.). No more wasted time looking through shared drives and folders.